Results 151 to 160 of about 836,416 (221)

Nano-immunotherapy: Merging immunotherapy precision with nanomaterial delivery. [PDF]

iScience
Ngo TH, Menon S, Rivero-Müller A.
europepmc   +1 more source

NKG2D/CD28 chimeric receptor boosts cytotoxicity and durability of CAR-T cells for solid and hematological tumors. [PDF]

Exp Hematol Oncol
Teng X, Li S, Zhang C, Ding H, Tian Z, Zhu Y, Liu T, Zhang G, Sun K, Xie H, Tu J, Lu Z.   +11 more
europepmc   +1 more source

Calibration of CAR activation potential directs alternative T cell fates and therapeutic potency

Nature Network Boston, 2018
J. Feucht, Jie Sun, Justin Eyquem, Yu-jui Ho, Zeguo Zhao, J. Leibold, Anton Dobrin, Annalisa Cabriolu, Mohamad Hamieh, M. Sadelain   +9 more
semanticscholar   +1 more source

Research Progress on the Immune Function of Liver Sinusoidal Endothelial Cells in Sepsis. [PDF]

Cells
Wang X, Guo Z, Xia Y, Wang X, Wang Z.
europepmc   +1 more source

Natural killer cells in multiple sclerosis: foe or friends? [PDF]

Front Cell Neurosci
Aghaee F, Abedinpour M, Anvari S, Saberi A, Fallah A, Bakhshi A.   +5 more
europepmc   +1 more source

Exploring the potential of CAR-NK cell therapy in the management of head and neck cancer (HNC): a narrative review. [PDF]

Ann Med Surg (Lond)
Zare E, Mostafavi SM, Norouzi N, Larijani A, Mosavi Mirkalaie SM, FallahMortezaNejad SA, Jafari M, Shahabinejad E, Aghaei Lasboo M, Anvari S.   +9 more
europepmc   +1 more source

Enhancing CAR T-Cell Function with Domains of Innate Immunity Sensors. [PDF]

Int J Mol Sci
Mlakar T, Skrbinek M, Fink T, Lainšček D.   +3 more
europepmc   +1 more source

Tuning TCR complex recruitment to the T cell antigen coupler (TAC) enhances TAC-T cell function. [PDF]

Sci Rep
Morey TM, Benatar T, Xu SX, Wang L, Ip P, Nitya-Nootan T, Thakor G, Bader AG, Helsen CW, Houry WA.   +9 more
europepmc   +1 more source

γδT cells, a key subset of T cell for cancer immunotherapy. [PDF]

Front Immunol
Lv J, Liu Z, Ren X, Song S, Zhang Y, Wang Y.   +5 more
europepmc   +1 more source

The XBB.1.5 mRNA booster vaccine does not significantly increase the percentage of XBB.1.5 mono-reactive T cells. [PDF]

Front Immunol
Sop J, Mercado A, Figueroa A, Beckey TP, Traut CC, Zhang L, Smith KN, Blankson JN.   +7 more
europepmc   +1 more source